July 1 (Reuters) – Bayer said on Wednesday it is consolidating its U.S. glyphosate business into ‌its Ruveon unit, a day after it asked ‌Washington to impose duties on Chinese imports of the chemical used ​in the company’s weedkiller Roundup.

• Bayer, the only U.S. maker of glyphosate, sought duties against Chinese imports of the chemical and said on Tuesday that “the domestic ‌glyphosate business as ⁠it stands today is not sustainable”, angering farmers who said such a move would ⁠raise herbicide costs.

• The St. Louis-based unit, which remains a Bayer business, will oversee all aspects of U.S. ​glyphosate sales, ​including pricing, go-to-market strategies, ​production and logistics, the ‌company said on Wednesday.

• Bayer said the consolidation of the business was part of its Crop Science division’s five-year restructuring plan.

• “Ruveon is expected to be a more nimble and well-positioned player within its commodity-based ‌market, which requires a specialized approach ​to address competitive dynamics,” Bayer ​said.

• Last week, ​the German pharmaceuticals and agriculture group ‌scored a major legal victory ​when the U.S. ​Supreme Court blocked thousands of state-court lawsuits that accuse Bayer of failing to warn users that ​glyphosate causes ‌cancer.

• Ruveon will be led by Bayer veteran ​Alfonso Alba Ordonez.

(Reporting by Bipasha Dey in Bengaluru; ​Editing by Sherry Jacob-Phillips)